Vemurafenib Recruiting Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01531361Sorafenib or Crizotinib and Vemurafenib in Advanced Cancer
NCT01787500Vemurafenib, Cetuximab, and Irinotecan in Advanced Solid Cancers